Showing 1 - 20 results of 30 for search 'Nielsen, C.', query time: 0.07s
Refine Results
-
1
-
2
-
3
-
4
-
5
-
6
The influence of neighborhood types on active transport in China’s growing cities by Guan, C, Srinivasan, S, Zhang, B, Da, L, Liu, J, Nielsen, C
Published 2020Journal article -
7
Modeling spin relaxation in complex radical systems using MolSpin by Gerhards, L, Nielsen, C, Kattnig, DR, Hore, P, Solov’yov, IA
Published 2023Journal article -
8
Ascorbic acid may not be involved in cryptochrome-based magnetoreception by Nielsen, C, Kattnig, DR, Sjulstok, E, Hore, PJ, Solov'yov, IA
Published 2017Journal article -
9
-
10
Malaria vaccines: Recent advances and new horizons by Draper, S, Sack, B, King, C, Nielsen, C, Rayner, J, Higgins, M, Long, C, Seder, R
Published 2018Journal article -
11
-
12
Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant... by Vinner, L, Wee, E, Patel, S, Corbet, S, Gao, G, Nielsen, C, Wilson, J, Ertl, H, Hanke, T, Fomsgaard, A
Published 2003Journal article -
13
-
14
-
15
SiteChar – Methodology for a Fit-for-Purpose Assessment of CO2 Storage Sites in Europe by Delprat-Jannaud F., Pearce J., Akhurst M., Nielsen C.M., Neele F., Lothe A., Volpi V., Brunsting S., Vincké O.
Published 2015-04-01
Article -
16
Techno-Economic Assessment of Four CO2 Storage Sites by Gruson J.-F., Serbutoviez S., Delprat-Jannaud F., Akhurst M., Nielsen C., Dalhoff F., Bergmo P., Bos C., Volpi V., Iacobellis S.
Published 2015-04-01
Article -
17
Protein/AS01B vaccination elicits stronger, more Th2-skewed antigen-specific human T follicular helper cell responses than heterologous viral vectors by Nielsen, C, Ogbe, A, Pedroza-Pacheco, I, Doeleman, S, Silk, S, Barrett, J, Elias, S, Bardelli, M, Dabbs, R, Barfod, L, Payne, R, Minassian, A, Draper, S, Borrow, P
Published 2021Journal article -
18
In silico T cell epitope prediction identifies high value RH5 epitopes that correlate with response in vaccinees by Terry, F, Noe, A, Hindocha, P, Silk, S, Nielsen, C, Gupta, R, Kotraiah, V, Nugent, F, Minassian, A, Ardito, M, Soisson, L, Diggs, C, Miller, R, Moise, L, Martin, W, De Groot, A, Tucker, K, Phares, T, Ashfield, R, Gutierrez, G, Draper, S
Published 2018Conference item -
19
Treatment-associated polymorphisms in protease are significantly associated with higher viral load and lower CD4 count in newly diagnosed drug-naive HIV-1 infected patients. by Theys, K, Deforche, K, Vercauteren, J, Libin, P, van de Vijver, D, Albert, J, Asjö, B, Balotta, C, Bruckova, M, Camacho, R, Clotet, B, Coughlan, S, Grossman, Z, Hamouda, O, Horban, A, Korn, K, Kostrikis, L, Kücherer, C, Nielsen, C, Paraskevis, D, Poljak, M, Puchhammer-Stockl, E, Riva, C, Ruiz, L, Liitsola, K
Published 2012Journal article -
20
Efficacy of the novel Plasmodium falciparum blood-stage vaccine RH5.1/AS01B in a phase I/IIA clinical trial by Minassian, A, Silk, S, Poulton, I, Mitton, C, Payne, R, Rawlinson, T, Barrett, J, Baker, M, Ramon, R, Lopez, F, Edwards, N, Ellis, K, Nielsen, C, Quinkert, D, Barfod, L, Miura, K, Diouf, A, Folegatti, P, Silman, D, Datoo, M, Smith, R, Berrie, E, Morelle, D, Lievens, M, Noe, A, Diggs, C, Soisson, L, Ashfield, R, Long, C, Nugent, F, Lawrie, A, Draper, S
Published 2018Conference item